CD8A and neoplasm: In line with this, Hh pathway inhibitor induced tumor regression and accompanied by recruitment of CD4+ and cytotoxic CD8+ T cells and an upregulation of MHC class I according to IHC analysis of biopsies from patients with BCC, indicating the activation of immune microenvironment (132).